Prospective, randomized, open-label, clinical trial comparing the different Sufonyl Urea(SU) combination with DPP4 inhibitor
Phase 4
- Conditions
- Diabetes Mellitus
- Registration Number
- JPRN-UMIN000003006
- Lead Sponsor
- Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1.History of hypersensitivity to sulfonyl urea or sitagliptin 2.During the pregnancy and nursing 3. Severe renal dysfunction (serum creatinin>2.0mg/dl) 4. Severe liver dysfunction (AST, ALT>50IU/ml) 5. 6.Inadequate to entry this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method